Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

2.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

3.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

4.

Surgery may not be necessary to treat invasive breast cancer

5.

Why are so many young adults getting cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot